Signaling transduction: target in osteoarthritis

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) pathophysiology involves an imbalance between anabolic and catabolic pathways.
• Joint cell activation by inflammatory mediators, matrix components, and mechanical stress drives this imbalance.
• Mediators signal through receptors to activate gene transcription for matrix metalloproteinases and inflammatory genes.

Purpose of the Study:

• To explore the potential of targeting intracellular signaling pathways in osteoarthritis.
• To modulate the imbalance between anabolic and catabolic pathways in OA.
• To review novel therapeutic approaches for OA based on signaling pathway modulation.

Main Methods:

• Review of current literature on cellular signaling in osteoarthritis.
• Identification of key signaling pathways involved in OA pathogenesis, including nuclear factor-kappaB (NF-κB) and mitogen-activated protein kinase (MAPK).
• Analysis of experimental studies on inhibitors targeting these pathways in arthritis and OA models.

Main Results:

• NF-κB and MAPK pathways are critical in OA for expressing metalloproteinases and inflammatory genes.
• Other molecules like nitric oxide and peroxisome proliferator-activated receptor-gamma ligands also contribute to OA cell activation.
• Experimental inhibitors (e.g., p38 MAPK, NF-κB inhibitors) show promising results in preclinical arthritis models.

Conclusions:

• Targeting specific signaling pathways in OA was previously considered complex due to pathway redundancy.
• Recent advances reveal key chondrocyte and synoviocyte signaling mechanisms in OA.
• Inhibitors of specific signaling pathways may offer effective future treatments for osteoarthritis.